LARGE CELL NEUROENDOCRINE CARCINOMA OF THE LUNG
Clinical trials for LARGE CELL NEUROENDOCRINE CARCINOMA OF THE LUNG explained in plain language.
Never miss a new study
Get alerted when new LARGE CELL NEUROENDOCRINE CARCINOMA OF THE LUNG trials appear
Sign up with your email to follow new studies for LARGE CELL NEUROENDOCRINE CARCINOMA OF THE LUNG, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail aims to tame rare lung cancer
Disease control Not yet recruitingThis study tests whether adding a new drug, obrixtamig, to standard chemotherapy can help people with a rare and aggressive lung cancer called large-cell neuroendocrine carcinoma (LCNEC). The trial will include 75 adults with advanced LCNEC that cannot be cured by surgery. Resear…
Matched conditions: LARGE CELL NEUROENDOCRINE CARCINOMA OF THE LUNG
Phase: PHASE2 • Sponsor: Technische Universität Dresden • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Triple-Drug cocktail takes aim at rare, aggressive cancers
Disease control Not yet recruitingThis phase 2 trial tests a combination of three drugs—benmelstobart (an immunotherapy), anlotinib (a targeted therapy), and standard chemotherapy—as a first treatment for people with large-cell neuroendocrine carcinoma of the lung or similar cancers outside the lung. The study ai…
Matched conditions: LARGE CELL NEUROENDOCRINE CARCINOMA OF THE LUNG
Phase: PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC